NCT07196488 Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
| NCT ID | NCT07196488 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taipei University of Nursing and Health Sciences |
| Condition | Prostate Cancer (Adenocarcinoma) |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-10-13 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-10-13 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to help patients with prostate cancer and their spouses cope better with the challenges of cancer by learning and supporting each other together. The investigators will test an 8-week "Dyadic Co-learning Intervention," which includes weekly learning topics, a mobile app, and professional support. The goal is to improve their physical symptoms, emotional well-being, and resilience. Participants will be randomly assigned to one of two groups. One group will receive regular care, while the other group will receive regular care plus the new co-learning program. The investigators will ask both patients and their spouses to complete questionnaires at the beginning of the study, and again at 10 and 16 weeks, to understand how the program affects their health and well-being.
Eligibility Criteria
Inclusion Criteria: For Patients: 1. Diagnosed with prostate cancer by a board-certified urologist. 2. Has either decided on a treatment plan or completed treatment within the past two years. 3. Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. For Spouses: 1. Must be a cohabiting spouse of the prostate cancer patient and aged 20 years or older. 2. Must have a Barthel Index score of 91 or above, indicating good functional independence. Exclusion Criteria: Either the patient or the spouse will be excluded if: 1. Diagnosed with another type of cancer. 2. Diagnosed with cognitive impairment or a psychiatric disorder, such as dementia, depression, or anxiety.
Contact & Investigator
Ching-Hui Chien
PRINCIPAL INVESTIGATOR
National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.
Frequently Asked Questions
Who can join the NCT07196488 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 90 Years, studying Prostate Cancer (Adenocarcinoma). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07196488 currently recruiting?
Yes, NCT07196488 is actively recruiting participants. Contact the research team at chinghui@ntunhs.edu.tw for enrollment information.
Where is the NCT07196488 trial being conducted?
This trial is being conducted at Keelung, Taiwan, Taoyuan, Taiwan.
Who is sponsoring the NCT07196488 clinical trial?
NCT07196488 is sponsored by National Taipei University of Nursing and Health Sciences. The principal investigator is Ching-Hui Chien at National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.